FdaApplication
NDA 010996
Identifiers
- fda_app_no: NDA010996
Properties
| Property | Value |
|---|---|
| applicant_name | XANODYNE PHARMACEUTICS INC |
| application_type | NDA |
| approval_date | 1983-03-08 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DARVON COMPOUND | ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE | 389MG;32.4MG;32MG | CAPSULE;ORAL |
| DARVON COMPOUND-65 | ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE | 389MG;32.4MG;65MG | CAPSULE;ORAL |
| DARVON W/ ASA | ASPIRIN; PROPOXYPHENE HYDROCHLORIDE | 325MG;65MG | CAPSULE;ORAL |
3 products